resisttb
- May 10
- 1 min read

New safer and shorter drug-resistant TB treatment must be scaled up

Médecins Sans Frontières (MSF) calls on governments and donors to speed up access to new, shorter, safer and more effective treatments for drug-resistant tuberculosis (DR-TB). MSF joined the World Health Organization (WHO) and other organisations in a ‘Call to Action’ ahead of World TB Day. MSF also urges the US-based diagnostics corporation Cepheid to drop the price of the critical GeneXpert tests, and for governments to scale up access to diagnostic test, to ensure that people with DR-TB can be diagnosed in time to access the shorter and safer treatment regimens. Read more here.

Recent Posts

See All

Why is a curable disease allowed to kill millions?

John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks

International consensus highlights the importance of molecular testing for MDR-TB

A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibio

Sweet advance for treatment of children with multi-drug resistant TB

Children with multi-drug resistant tuberculosis (MDR-TB) undergo months of life-saving treatment including many doses of foul-tasting medications, which caregivers often struggle to prepare and admini